Prodeon Medical announced the completion of patient enrollment for the Expander-2 Pivotal Trial, a study evaluating the Urocross Expander System for minimally invasive treatment of Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH). SUNNYVALE, Calif. , Jan. 6,...
↧